Lysophosphatidic acid (LPA) protects primary chronic lymphocytic leukemia (CLL) cells from apoptosis: Role for LPA as a survival factor in CLL.

被引：0
|
作者：
Gibson, SB [1 ]
Hu, XJ [1 ]
Haney, N [1 ]
Kabore, AF [1 ]
Johnston, JB [1 ]
机构：
[1] Univ Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB, Canada
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.4788.4788
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4788
引用
收藏
页码：280B / 280B
页数：1
相关论文
共 50 条
  • [41] PHORBOL ESTER(TPA)-INDUCED IG SECRETION IN CHRONIC LYMPHOCYTIC-B LEUKEMIA (CLL) CELLS - ROLE OF ACCESSORY CELLS
    DANERSUND, A
    TOTTERMAN, TH
    NILSSON, K
    SJOBERG, O
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1982, 16 (05) : 443 - 443
  • [42] The level of vascular endothelial growth factor receptor-2 in peripheral blood chronic lymphocytic leukemia (CLL) cells correlates with patient survival.
    Ferrajoli, A
    Estrov, Z
    Keating, M
    Lemer, S
    Manshouri, T
    Beran, M
    Kantarjian, H
    Albitar, M
    BLOOD, 1999, 94 (10) : 536A - 536A
  • [43] IDEC-152 (anti-CD23) triggers apoptosis of chronic lymphocytic leukemia (CLL) cells in vitro.
    Hopkins, MT
    Pathan, N
    Chu, P
    Grint, P
    Saven, A
    BLOOD, 2002, 100 (11) : 597A - 597A
  • [44] p53 Homolog TAp63 elicits apoptosis in Chronic Lymphocytic Leukemia (CLL) B-Cells
    Collins, Ryan
    Kaur, Prabhjot
    Danilova, Olga
    Direnzo, James
    Danilov, Alexey V.
    BLOOD, 2011, 118 (21) : 1664 - 1664
  • [45] Erratum: VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance
    Y K Lee
    T D Shanafelt
    N D Bone
    A K Strege
    D F Jelinek
    N E Kay
    Leukemia, 2010, 24 : 908 - 908
  • [46] IGHV Unmutated Chronic Lymphocytic Leukemia (CLL) B Cells Are More Susceptible to Spontaneous Apoptosis Than Mutated CLL B Cells and Are Subject to the Anti-Apoptotic Effect of Environmental Signals
    Coscia, Marta
    Pantaleoni, Francesca
    Riganti, Chiara
    Vitale, Candida
    Rigoni, Micol
    Peola, Silvia
    Drandi, Daniela
    Castella, Barbara
    Ruggeri, Marina
    Omede, Paola
    Ladetto, Marco
    Bosia, Amalia
    Boccadoro, Mario
    Massaia, Massimo
    BLOOD, 2010, 116 (21) : 1008 - 1008
  • [47] A novel pro-survival and proliferation-inducing role for CCR4:TARC interaction in chronic lymphocytic leukemia (CLL) B cells
    Damle, Rajendra
    Temburni, Sonal
    Malavasi, Fabio
    Kaufman, Matthew
    Kolitz, Jonathan
    Allen, Steven
    Rai, Kanti
    Chiorazzi, Nicholas
    JOURNAL OF IMMUNOLOGY, 2010, 184
  • [48] Novel Putative Driver Gene Mutations in Chronic Lymphocytic Leukemia (CLL): Results from a Combined Analysis of Whole-Exome Sequencing of 262 Primary CLL Samples
    Landau, Dan A.
    Stewart, Chip
    Reiter, Johannes G.
    Lawrence, Michael
    Sougnez, Carrie
    Brown, Jennifer R.
    Lopez-Guillermo, Armando
    Gabriel, Stacey
    Lander, Eric
    Neuberg, Donna S.
    Lopez-Otin, Carlos
    Campo, Elias
    Getz, Gad
    Wu, Catherine J.
    BLOOD, 2014, 124 (21)
  • [49] The geldanalmycin derivative DMAG demonstrates improved cytotoxicity and down-modulation of Hsp90 client proteins relative to 17-AAG in chronic lymphocytic leukemia (CLL) cells: Justification for clinical trials in CLL.
    Johnson, Amy J.
    Wagner, Amy J.
    Smith, Lisa L.
    Lucas, David M.
    De Lay, Michael D.
    Allison, Jamie M.
    Ivy, S. Percy
    Lin, Thomas S.
    Byrd, John C.
    BLOOD, 2006, 108 (11) : 596A - 596A
  • [50] Neuropilin-1 receptor blocking antibodies induce cell death in primary chronic lymphocytic leukemia (CLL) B cells
    Nowakowski, G. S.
    Lee, Y. K.
    Bone, N.
    Kay, N. E.
    EXPERIMENTAL HEMATOLOGY, 2006, 34 (09) : 68 - 69
12345